CMS has issued the following Medicare billing guidance regarding the FDA-approved updated COVID-19 vaccines for the 2024–2025 season:
- mRNA vaccines made by Pfizer-BioNTech and Moderna on August 22, 2024
- Novavax COVID-19 Vaccine, Adjuvanted on August 30, 2024
CMS has also updated COVID-19 vaccine pricing for the 2024–2025 season:
- CPT codes 91318–91322, effective August 22, 2024 (Note: no change to payment allowances from last season for 91318–91319)
- CPT code 91304, effective August 30, 2024
- Use CPT code 90480 to bill for the administration of the vaccine.
Please see the CMS COVID-19 Vaccine Provider Toolkit for more information.